However, the use of barbiturates as sedatives while in the postoperative surgical time period and as adjuncts to cancer chemotherapy is very well set up.pentobarbital will decrease the extent or impact of cobimetinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Stay clear of coadministration. Sturdy or moderate CYP3A i